Editorial: Intermittent Fasting - Mechanisms and Clinical Usefulness

Front Endocrinol (Lausanne). 2021 Sep 14:12:757539. doi: 10.3389/fendo.2021.757539. eCollection 2021.

Andreas Fritsche^{1

2

3}, Julia Szendrödi^{3

4}, Annette Schürmann^{3

5}

¹ Medical Clinic IV, University of Tübingen, Tübingen, Germany.
² Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
³ German Center for Diabetes Research (DZD), Neuherberg, Germany.
⁴ Department of Internal Medicine 1 and Clinical Chemistry, Heidelberg University Hospital, Heidelberg, Germany.
⁵ Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

No abstract available

Keywords: Parkinsons disease; intermittent fasting; metabolic syndrome; type 1 diabetes; type 2 diabetes.

Publication types